| scholarly article | Q13442814 |
| P50 | author | Thomas C. Südhof | Q97270 |
| Henrik Ahlenius | Q55436891 | ||
| Soham Chanda | Q56894770 | ||
| Marius Wernig | Q74884461 | ||
| P2093 | author name string | Ernesto Lujan | |
| P2860 | cites work | Nuclear reprogramming and stem cell creation | Q24620354 |
| Dynamic transcriptomes during neural differentiation of human embryonic stem cells revealed by short, long, and paired-end sequencing | Q24620865 | ||
| Direct conversion of fibroblasts to functional neurons by defined factors | Q24641912 | ||
| Niche-independent symmetrical self-renewal of a mammalian tissue stem cell | Q24812526 | ||
| Direct lineage conversion of terminally differentiated hepatocytes to functional neurons | Q26269878 | ||
| Induction of human neuronal cells by defined transcription factors | Q26269896 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| In vivo reprogramming of adult pancreatic exocrine cells to beta-cells | Q28292190 | ||
| Viable offspring derived from fetal and adult mammalian cells | Q28304072 | ||
| Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors | Q28589872 | ||
| Expression of a single transfected cDNA converts fibroblasts to myoblasts | Q29547764 | ||
| Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts | Q29614794 | ||
| Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy | Q34025541 | ||
| Direct conversion of human fibroblasts to multilineage blood progenitors. | Q34148584 | ||
| Direct reprogramming of mouse fibroblasts to neural progenitors | Q34180572 | ||
| Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors | Q34184375 | ||
| Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. | Q34196432 | ||
| SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult | Q34394410 | ||
| Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors | Q34686624 | ||
| Extreme makeover: converting one cell into another | Q34862000 | ||
| Nuclear reprogramming in cells | Q34907992 | ||
| A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types | Q37124767 | ||
| How fixed is the differentiated state? Lessons from heterokaryons | Q38727748 | ||
| PDX-1/VP16 fusion protein, together with NeuroD or Ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance | Q40442233 | ||
| Generation of purified oligodendrocyte progenitors from embryonic stem cells | Q40504006 | ||
| Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial-astroglial progenitor cells | Q41108824 | ||
| Effect of cell history on response to helix-loop-helix family of myogenic regulators | Q41740034 | ||
| Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage | Q42943701 | ||
| Chicken "erythroid" cells transformed by the Gag-Myb-Ets-encoding E26 leukemia virus are multipotent | Q45878338 | ||
| Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells | Q46885318 | ||
| Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. | Q48829693 | ||
| Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells | Q48906562 | ||
| c-Myc is dispensable for direct reprogramming of mouse fibroblasts. | Q55049543 | ||
| Tau EGFP embryonic stem cells: An efficient tool for neuronal lineage selection and transplantation | Q58047155 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2527-32 | |
| P577 | publication date | 2012-02-14 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells | |
| P478 | volume | 109 |
| Q26859884 | "Seq-ing" insights into the epigenetics of neuronal gene regulation |
| Q26746033 | A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects |
| Q27680151 | A Structural Analysis of DNA Binding by Myelin Transcription Factor 1 Double Zinc Fingers |
| Q36290925 | A Systematic Approach to Identify Candidate Transcription Factors that Control Cell Identity |
| Q34320191 | A blueprint for engineering cell fate: current technologies to reprogram cell identity |
| Q33628922 | A mouse tissue transcription factor atlas |
| Q38038516 | Accelerating progress in induced pluripotent stem cell research for neurological diseases |
| Q30585772 | Activation of neural cell fate programs toward direct conversion of adult human fibroblasts into tri-potent neural progenitors using OCT-4. |
| Q55093717 | Adult Neural Stem Cells: Basic Research and Production Strategies for Neurorestorative Therapy. |
| Q38129192 | Adult-derived pluripotent stem cells |
| Q38092765 | Advances in cell lineage reprogramming |
| Q34550774 | Advances in culture and manipulation of human pluripotent stem cells |
| Q36357908 | Advances in stem cell therapy for spinal cord injury |
| Q36882491 | Autologous iPSC-derived dopamine neuron transplantation in a nonhuman primate Parkinson's disease model |
| Q38104829 | Bioengineered stem cells in neural development and neurodegeneration research |
| Q38829948 | Brain repair and reprogramming: the route to clinical translation. |
| Q36262775 | Brief exposure to small molecules allows induction of mouse embryonic fibroblasts into neural crest-like precursors |
| Q36201384 | CEND1 and NEUROGENIN2 Reprogram Mouse Astrocytes and Embryonic Fibroblasts to Induced Neural Precursors and Differentiated Neurons |
| Q37725247 | CG hypomethylation in Lsh-/- mouse embryonic fibroblasts is associated with de novo H3K4me1 formation and altered cellular plasticity |
| Q37195906 | Cardiac reprogramming: from mouse toward man. |
| Q26776041 | Cell Therapy for Parkinson's Disease: New Hope from Reprogramming Technologies |
| Q38730766 | Cell fate modification toward the hepatic lineage by extrinsic factors. |
| Q38068560 | Cell therapy: the final frontier for treatment of neurological diseases. |
| Q37204530 | Cellular reprogramming: a novel tool for investigating autism spectrum disorders |
| Q37618021 | Changing POU dimerization preferences converts Oct6 into a pluripotency inducer |
| Q48466082 | Characterization of brain cell nuclei with decondensed chromatin |
| Q34329654 | Characterization of induced neural progenitors from skin fibroblasts by a novel combination of defined factors |
| Q26996654 | Co-ordination of cell cycle and differentiation in the developing nervous system |
| Q90140919 | Combination of Chemical and Neurotrophin Stimulation Modulates Neurotransmitter Receptor Expression and Activity in Transdifferentiating Human Adipose Stromal Cells |
| Q37217420 | Comparative neuronal differentiation of self-renewing neural progenitor cell lines obtained from human induced pluripotent stem cells |
| Q36568988 | Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer |
| Q57175624 | Concepts toward directing human astroplasticity to promote neuroregeneration |
| Q45305684 | Concise Review: The Use of Stem Cells for Understanding and Treating Huntington's Disease. |
| Q34666395 | Concise review: chemical approaches for modulating lineage-specific stem cells and progenitors |
| Q38063851 | Concise review: self-renewal in the central nervous system: neural stem cells from embryo to adult. |
| Q38118544 | Concise review: the involvement of SOX2 in direct reprogramming of induced neural stem/precursor cells |
| Q36805048 | Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor. |
| Q59137392 | Conversion of adult human fibroblasts into neural precursor cells using chemically modified mRNA |
| Q33924616 | Converted neural cells: induced to a cure? |
| Q24623575 | Cord blood-derived neuronal cells by ectopic expression of Sox2 and c-Myc |
| Q52568314 | Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer's Disease. |
| Q44784006 | Current progress in the derivation and therapeutic application of neural stem cells. |
| Q38691178 | Current status of treating neurodegenerative disease with induced pluripotent stem cells |
| Q36906650 | Dachshund binds p53 to block the growth of lung adenocarcinoma cells |
| Q38120531 | Deconstructing mitochondrial dysfunction in Alzheimer disease |
| Q41051710 | Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells |
| Q35058643 | Derivation of neural stem cells from human adult peripheral CD34+ cells for an autologous model of neuroinflammation |
| Q27347937 | Differentiated type II pneumocytes can be reprogrammed by ectopic Sox2 expression |
| Q38875265 | Direct Conversion of Cord Blood CD34+ Cells Into Neural Stem Cells by OCT4. |
| Q37583579 | Direct Conversion of Human Fibroblasts into Neural Progenitors Using Transcription Factors Enriched in Human ESC-Derived Neural Progenitors |
| Q47153836 | Direct Conversion of Human Umbilical Cord Blood into Induced Neural Stem Cells with SOX2 and HMGA2. |
| Q40963969 | Direct Reprogramming of Mouse Fibroblasts to Neural Stem Cells by Small Molecules. |
| Q37596398 | Direct conversion of human fibroblasts into neuronal restricted progenitors |
| Q58612523 | Direct conversion of mouse astrocytes into neural progenitor cells and specific lineages of neurons |
| Q42392881 | Direct conversion of mouse embryonic fibroblasts into functional keratinocytes through transient expression of pluripotency-related genes |
| Q48325835 | Direct conversion of mouse fibroblasts into induced neural stem cells |
| Q37495227 | Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS |
| Q35162046 | Direct induction of human neural stem cells from peripheral blood hematopoietic progenitor cells |
| Q34451120 | Direct lineage conversion of adult mouse liver cells and B lymphocytes to neural stem cells |
| Q38411899 | Direct lineage conversion of astrocytes to induced neural stem cells or neurons |
| Q27025605 | Direct lineage conversion: induced neuronal cells and induced neural stem cells |
| Q37095402 | Direct lineage reprogramming to neural cells |
| Q38916937 | Direct lineage reprogramming via pioneer factors; a detour through developmental gene regulatory networks. |
| Q38195398 | Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy |
| Q59758209 | Direct reprogramming of fibroblasts into neural stem cells by single non-neural progenitor transcription factor Ptf1a |
| Q34280164 | Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor |
| Q38051201 | Direct reprogramming of mouse fibroblasts into cardiac myocytes |
| Q42427157 | Direct reprogramming of porcine fibroblasts to neural progenitor cells |
| Q38594907 | Direct somatic lineage conversion |
| Q42035941 | Dissecting engineered cell types and enhancing cell fate conversion via CellNet |
| Q48239230 | Diversity among POU transcription factors in chromatin recognition and cell fate reprogramming. |
| Q59101361 | Efficient reprogramming of mouse fibroblasts to neuronal cells including dopaminergic neurons |
| Q30851277 | Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators. |
| Q38085796 | Endodermal stem cell populations derived from pluripotent stem cells |
| Q37206992 | Environmental impact on direct neuronal reprogramming in vivo in the adult brain |
| Q35224744 | Epigenetic landscapes explain partially reprogrammed cells and identify key reprogramming genes |
| Q38037969 | Epigenetic obstacles encountered by transcription factors: reprogramming against all odds |
| Q38365535 | Epigenetic regulation in stem cell development, cell fate conversion, and reprogramming. |
| Q36562984 | Epigenetics of early-life lead exposure and effects on brain development |
| Q38838046 | Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience |
| Q90319236 | Evolving principles underlying neural lineage conversion and their relevance for biomedical translation |
| Q38454090 | Experimental Advances Towards Neural Regeneration from Induced Stem Cells to Direct In Vivo Reprogramming. |
| Q34684538 | Fast and efficient neural conversion of human hematopoietic cells |
| Q48355054 | Fibroblast growth factor 4 is required but not sufficient for the astrocyte dedifferentiation |
| Q28087195 | Forward engineering neuronal diversity using direct reprogramming |
| Q38366783 | From demyelination to remyelination: the road toward therapies for spinal cord injury |
| Q64255578 | GATA3 Promotes the Neural Progenitor State but Not Neurogenesis in 3D Traumatic Injury Model of Primary Human Cortical Astrocytes |
| Q35837181 | Generation of Dopamine Neurons from Rodent Fibroblasts through the Expandable Neural Precursor Cell Stage. |
| Q37065748 | Generation of Integration-free Induced Neural Stem Cells from Mouse Fibroblasts |
| Q26765258 | Generation of diverse neural cell types through direct conversion |
| Q37205314 | Generation of integration-free and region-specific neural progenitors from primate fibroblasts |
| Q36209829 | Generation of integration-free induced hepatocyte-like cells from mouse fibroblasts |
| Q33701798 | Generation of neural progenitor cells by chemical cocktails and hypoxia |
| Q34339119 | Generation of oligodendroglial cells by direct lineage conversion. |
| Q37408786 | Generation of patient-specific induced neuronal cells using a direct reprogramming strategy |
| Q38264530 | Generation of pluripotent stem cells without the use of genetic material |
| Q36506647 | Generation of primitive neural stem cells from human fibroblasts using a defined set of factors |
| Q38177816 | Genomic and computational approaches to dissect the mechanisms of STAT3's universal and cell type-specific functions |
| Q52849684 | Getting More Skin in the Game: Using Human Neural Stem Cells Transdifferentiated From Fibroblasts to Target Malignant Gliomas. |
| Q38700229 | Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish |
| Q41918596 | H3K4me3 breadth is linked to cell identity and transcriptional consistency. |
| Q34162515 | Highly efficient generation of induced neurons from human fibroblasts that survive transplantation into the adult rat brain. |
| Q39114301 | Highly rapid and efficient conversion of human fibroblasts to keratinocyte-like cells |
| Q57274912 | Human Cytomegalovirus Immediate Early 1 Protein Causes Loss of SOX2 from Neural Progenitor Cells by Trapping Unphosphorylated STAT3 in the Nucleus |
| Q104577323 | Human sensory neurons derived from pluripotent stem cells for disease modelling and personalized medicine |
| Q26799285 | Importance of being Nernst: Synaptic activity and functional relevance in stem cell-derived neurons |
| Q30828997 | In Situ Pluripotency Factor Expression Promotes Functional Recovery From Cerebral Ischemia |
| Q26771027 | In Vivo Reprogramming for Brain and Spinal Cord Repair |
| Q34406755 | In vivo conversion of astrocytes to neurons in the injured adult spinal cord |
| Q34372623 | In vivo reprogramming of astrocytes to neuroblasts in the adult brain |
| Q45305883 | Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's Disease |
| Q38116769 | Induced Pluripotent Stem Cells and Disorders of the Nervous System: Progress, Problems, and Prospects |
| Q37592612 | Induced Pluripotent Stem Cells for Traumatic Spinal Cord Injury |
| Q28081780 | Induced Stem Cells as a Novel Multiple Sclerosis Therapy |
| Q38163443 | Induced neural lineage cells as repair kits: so close, yet so far away. |
| Q90351316 | Induced neural progenitor cells abundantly secrete extracellular vesicles and promote the proliferation of neural progenitors via extracellular signal-regulated kinase pathways |
| Q38110478 | Induced neural stem cells (iNSCs) in neurodegenerative diseases |
| Q34699705 | Induced neural stem cells achieve long-term survival and functional integration in the adult mouse brain |
| Q47651159 | Induced neural stem cells as a means of treatment in Huntington's disease. |
| Q41903175 | Induced neural stem cells generated from rat fibroblasts |
| Q34271972 | Induced neural stem cells: a new tool for studying neural development and neurological disorders |
| Q38528543 | Induced neural stem/precursor cells for fundamental studies and potential application in neurodegenerative diseases |
| Q33904255 | Induced neuronal reprogramming |
| Q38107885 | Induced pluripotency and direct reprogramming: a new window for treatment of neurodegenerative diseases |
| Q28081025 | Induced pluripotent stem cell-derived neural stem cell therapies for spinal cord injury |
| Q28547193 | Induction of Neural Progenitor-Like Cells from Human Fibroblasts via a Genetic Material-Free Approach |
| Q39401906 | Induction of a hemogenic program in mouse fibroblasts |
| Q30542130 | Induction of human cardiomyocyte-like cells from fibroblasts by defined factors |
| Q58107623 | Laying the groundwork for a first-in-human study of an iPSC-based intervention for spinal cord injury |
| Q38088936 | Leveling Waddington: the emergence of direct programming and the loss of cell fate hierarchies. |
| Q36825447 | Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage |
| Q38040304 | Lineage conversion methodologies meet the reprogramming toolbox |
| Q42214822 | Lineage-reprogramming of pericyte-derived cells of the adult human brain into induced neurons |
| Q96126798 | Machine learning uncovers cell identity regulator by histone code |
| Q34096351 | Mash1 efficiently reprograms rat astrocytes into neurons. |
| Q57036355 | Matrices, scaffolds & carriers for cell delivery in nerve regeneration |
| Q36861769 | Meeting report: using stem cells for biological and therapeutics discovery in mental illness, April 2012. |
| Q40061010 | Methods of reactivation and reprogramming of neural stem cells for neural repair |
| Q35648513 | MicroRNA-Mediated In Vitro and In Vivo Direct Conversion of Astrocytes to Neuroblasts. |
| Q93337870 | Mitochondria as central regulators of neural stem cell fate and cognitive function |
| Q38170728 | Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells |
| Q42099548 | Modeling schizophrenia using induced pluripotent stem cell-derived and fibroblast-induced neurons |
| Q37706859 | Modeling the phenotype of spinal muscular atrophy by the direct conversion of human fibroblasts to motor neurons |
| Q34512262 | Models of human core transcriptional regulatory circuitries |
| Q26822585 | Molecular roadblocks for cellular reprogramming |
| Q48160741 | Neural Crest Stem-Like Cells Non-genetically Induced from Human Gingiva-Derived Mesenchymal Stem Cells Promote Facial Nerve Regeneration in Rats |
| Q33722523 | Neural Progenitor-Like Cells Induced from Human Gingiva-Derived Mesenchymal Stem Cells Regulate Myelination of Schwann Cells in Rat Sciatic Nerve Regeneration. |
| Q39279957 | Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis |
| Q38143704 | Neural stem and progenitor cells in health and disease |
| Q33704489 | Neural stem cell therapy for cancer |
| Q26738352 | Neural stem/progenitor cells in Alzheimer's disease |
| Q52729618 | Neuronal replacement therapy: previous achievements and challenges ahead. |
| Q38609711 | New approaches for direct conversion of patient fibroblasts into neural cells |
| Q41902835 | Non-Viral Generation of Neural Precursor-like Cells from Adult Human Fibroblasts |
| Q58785850 | On the Viability and Potential Value of Stem Cells for Repair and Treatment of Central Neurotrauma: Overview and Speculations |
| Q39175458 | POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer |
| Q64864829 | Parkinson's disease: what the model systems have taught us so far |
| Q30842582 | Partial Reprogramming of Pluripotent Stem Cell-Derived Cardiomyocytes into Neurons. |
| Q34524445 | Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation. |
| Q37014278 | Physiological, pathological, and engineered cell identity reprogramming in the central nervous system |
| Q35050379 | Plant science. Fine-tuning photosynthesis |
| Q35424535 | Predicting involvement of polycomb repressive complex 2 in direct conversion of mouse fibroblasts into induced neural stem cells |
| Q35761135 | Probing disorders of the nervous system using reprogramming approaches |
| Q48385582 | RIT1 GTPase Regulates Sox2 Transcriptional Activity and Hippocampal Neurogenesis |
| Q26269862 | Rapid single-step induction of functional neurons from human pluripotent stem cells |
| Q26750951 | Rationale and Methodology of Reprogramming for Generation of Induced Pluripotent Stem Cells and Induced Neural Progenitor Cells |
| Q38733515 | Recent Progress in Cell Reprogramming Technology for Cell Transplantation Therapy |
| Q39004963 | Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells |
| Q35089532 | Regenerative Medicine for the Aging Brain |
| Q89768706 | Reprogrammed astrocytes display higher neurogenic competence, migration ability and cell death resistance than reprogrammed fibroblasts |
| Q55129556 | Reprogramming Glia Into Neurons in the Peripheral Auditory System as a Solution for Sensorineural Hearing Loss: Lessons From the Central Nervous System. |
| Q38264468 | Reprogramming cell fate: a changing story |
| Q47645196 | Reprogramming of somatic cells to induced neural stem cells |
| Q40832972 | Rewiring the ischaemic brain with human-induced pluripotent stem cell-derived cortical neurons |
| Q28554621 | Role of Hepatic-Specific Transcription Factors and Polycomb Repressive Complex 2 during Induction of Fibroblasts to Hepatic Fate |
| Q35831780 | SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence |
| Q34597982 | SOX2 co-occupies distal enhancer elements with distinct POU factors in ESCs and NPCs to specify cell state |
| Q35902185 | Selective Generation of Dopaminergic Precursors from Mouse Fibroblasts by Direct Lineage Conversion |
| Q96638742 | Sequentially induced motor neurons from human fibroblasts facilitate locomotor recovery in a rodent spinal cord injury model |
| Q57177827 | Single-Factor SOX2 Mediates Direct Neural Reprogramming of Human Mesenchymal Stem Cells via Transfection of In Vitro Transcribed mRNA |
| Q36105989 | Skin-derived neural precursors competitively generate functional myelin in adult demyelinated mice |
| Q37350844 | Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons |
| Q33793268 | Small molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming |
| Q92462846 | Sonic Hedgehog Effectively Improves Oct4-Mediated Reprogramming of Astrocytes into Neural Stem Cells |
| Q40934365 | Sox2 function as a negative regulator to control HAMP expression |
| Q38059176 | Specification of functional neurons and glia from human pluripotent stem cells |
| Q26775038 | Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions |
| Q38252939 | Stem Cells in Neurological Disorders: Emerging Therapy with Stunning Hopes. |
| Q37643268 | Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking |
| Q38058140 | Stem cell models of Alzheimer's disease and related neurological disorders |
| Q28085612 | Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives |
| Q38742380 | Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke |
| Q38929153 | Stem cells for spinal cord injury: Strategies to inform differentiation and transplantation |
| Q36586504 | Switching cell fate, ncRNAs coming to play |
| Q90396220 | Taking central nervous system regenerative therapies to the clinic: curing rodents versus nonhuman primates versus humans |
| Q26860309 | The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges |
| Q38722713 | The Therapeutic Potential of Cell Identity Reprogramming for the Treatment of Aging-Related Neurodegenerative Disorders |
| Q38081827 | The cellular memory disc of reprogrammed cells |
| Q90159661 | The core spliceosomal factor U2AF1 controls cell-fate determination via the modulation of transcriptional networks |
| Q55399267 | The developmental origin of brain tumours: a cellular and molecular framework. |
| Q26864510 | The genetics of hair cell development and regeneration |
| Q26830451 | The many roads to Rome: induction of neural precursor cells from fibroblasts |
| Q33843720 | The novel tool of cell reprogramming for applications in molecular medicine |
| Q26860841 | The potential for stem cell therapies to have an impact on cerebral palsy: opportunities and limitations |
| Q38109499 | The potential of stem cell research for the treatment of neuronal damage in glaucoma. |
| Q37025630 | The rise of cell therapy trials for stroke: review of published and registered studies |
| Q27333831 | Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma. |
| Q92861368 | Three-dimensional brain-like microenvironments facilitate the direct reprogramming of fibroblasts into therapeutic neurons |
| Q35213739 | Tissue-engineered regeneration of completely transected spinal cord using induced neural stem cells and gelatin-electrospun poly (lactide-co-glycolide)/polyethylene glycol scaffolds |
| Q90218457 | Transcription and Beyond: Delineating FOXG1 Function in Cortical Development and Disorders |
| Q34339127 | Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells. |
| Q34708573 | Transcription factors that convert adult cell identity are differentially polycomb repressed |
| Q36320692 | Transcriptomine, a web resource for nuclear receptor signaling transcriptomes |
| Q35805656 | Transdifferentiation of Fibroblasts by Defined Factors |
| Q27319949 | Transdifferentiation-Induced Neural Stem Cells Promote Recovery of Middle Cerebral Artery Stroke Rats |
| Q90336953 | Transgenic models for investigating the nervous system: Currently available neurofluorescent reporters and potential neuronal markers |
| Q96229976 | Transplanting neural progenitor cells to restore connectivity after spinal cord injury |
| Q48329121 | Tumor-homing cytotoxic human induced neural stem cells for cancer therapy. |
| Q37096574 | Tumourigenicity and Immunogenicity of Induced Neural Stem Cell Grafts Versus Induced Pluripotent Stem Cell Grafts in Syngeneic Mouse Brain |
| Q38204883 | Tuning cell fate: from insights to vertebrate regeneration |
| Q39085008 | Understanding Parkinson's Disease through the Use of Cell Reprogramming |
| Q30451361 | Understanding the evolution and development of neurosensory transcription factors of the ear to enhance therapeutic translation |
| Q64081249 | Using Dental Pulp Stem Cells for Stroke Therapy |
| Q27015087 | Using human induced pluripotent stem cells to treat retinal disease |
| Q39032069 | Zrf1 is required to establish and maintain neural progenitor identity |
| Q93141072 | mRNA-Driven Generation of Transgene-Free Neural Stem Cells from Human Urine-Derived Cells |
Search more.